The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma

Insights into the biology of advanced renal cell carcinoma (aRCC) and the development of agents targeting the vascular endothelial growth factor (VEGF) pathway have positively impacted the outcomes for patients with aRCC. With the recent approval of the dual immune checkpoint inhibitors (ICIs), nivo...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Asim, Hammers, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335326/
https://www.ncbi.nlm.nih.gov/pubmed/30687324
http://dx.doi.org/10.3389/fimmu.2018.03120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335326/
https://www.ncbi.nlm.nih.gov/pubmed/30687324
http://dx.doi.org/10.3389/fimmu.2018.03120

Ejemplares similares